(MENAFN- ProactiveInvestors - N.America) Summit Therapeutics PLC (NASDAQ:SMMT, LON:SUMM) said on Friday its chief financial officer Erik Ostrowski will present at the Canaccord Genuity Growth Conference, 11 August at 1:30pm EDT in Boston.
The London- and New York-listed drug discovery and development company seeks to advance therapies for Duchenne muscular dystrophy and Clostridium difficile infection.
Summit's ADRs were unchanged at $7.05 on Friday.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.